{
    "Trade/Device Name(s)": [
        "IMMAGE Systems Low Concentration Immunoglobulin A Reagent",
        "IMMAGE Systems Low Concentration Immunoglobulin A (IGALC) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K060130",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993549"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CZP"
    ],
    "Summary Letter Date": "February 13, 2006",
    "Summary Letter Received Date": "January 18, 2006",
    "Submission Date": "January 17, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D and E immunological systems"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Immunoglobulin A"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMAGE Immunochemistry Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Rate nephelometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for IMMAGE Systems Low Concentration Immunoglobulin A Reagent for quantitative measurement of immunoglobulin A in serum and cerebrospinal fluid by rate nephelometry",
    "Indications for Use Summary": "Intended for quantitative determination of Low Concentration Immunoglobulin A (IGALC) in human serum or cerebrospinal fluid by rate nephelometry to detect increased blood-CSF barrier permeability and intrathecal synthesis of immunoglobulins.",
    "fda_folder": "Immunology"
}